Viro Varicella-Zoster Virus Identification Reagent

FDA 510(k) K942743 · Viro Research, Inc.

Substantially Equivalent

510(k) numberK942743

Submission

Device name
Viro Varicella-Zoster Virus Identification Reagent
Applicant
Viro Research, Inc.
Rockford, IL, US
Received
June 10, 1994
Decision date
December 15, 1994
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GQW – Antigen, Cf, (Including Cf Control), Varicella-Zoster
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3900
Specialty
Microbiology

Other 510(k)s with product code GQW

510(k)DeviceApplicantDecision
K070206Diagnostic Hybrids D3 Dfa Varicella-Zoster Virus Identification Kit, 01-020000GQW · Traditional Diagnostic Hybrids, Inc.08/30/2007SE
K990141Light Diagnostics Simulfluor Hsv/Vzv Immunoflourescence Assay, Model 3295GQW · Traditional Light Diagnostics10/19/1999SE
K964872VZV Antigen Control SlidesGQW · Traditional Viral Antigens, Inc.03/18/1997SE
K912239Vzvscan(Tm) Latex Aggutination TestGQW · Traditional Bd Becton Dickinson Vacutainer Systems Preanalytic06/11/1991SE
K903882Varicella-Zoster Virus Antibody Test Kit-Latex AggGQW · Traditional Viral Antigens, Inc.12/04/1990SE
K894622Varicella Zoster VirusGQW · Traditional Bion Ent., Ltd.10/24/1989SE
K843676Varicella/Zoster VirusGQW · Traditional Institute Virion , Ltd.09/26/1985SE
K841434Varicella-Zoster(Igg) Ifa TestGQW · Traditional Zeus Scientific, Inc.04/19/1985SE
K802938Varicella-Zoster Antigens & ControlsGQW · Traditional Orion Diagnostica, Inc.12/31/1980SE

Questions and answers

When was Viro Varicella-Zoster Virus Identification Reagent cleared by the FDA?

Viro Varicella-Zoster Virus Identification Reagent (K942743) received a 510(k) decision of Substantially Equivalent on December 15, 1994, 188 days after the submission was received.

What is the product code of K942743?

The FDA product code is GQW – Antigen, Cf, (Including Cf Control), Varicella-Zoster, a Class II (moderate risk) device regulated under 21 CFR 866.3900.